Stocktoria
Caribou Biosciences, Inc. CRBU
Nasdaq · stock · Biological Products, (No Diagnostic Substances) · website · IPO 2021-07-23
Caribou Biosciences, Inc. institutional holders
| Investor | Shares | Value | % of company |
|---|---|---|---|
| BlackRock Finance, Inc. | 6,947,820 | $11.4M | 7.3% |
| RENAISSANCE TECHNOLOGIES LLC | 2,590,497 | $4.9M | 2.72% |
| TWO SIGMA INVESTMENTS, LP | 1,759,934 | $3.3M | 1.85% |
| MILLENNIUM MANAGEMENT LLC | 1,074,421 | $2.0M | 1.13% |
| CITADEL ADVISORS LLC | 297,933 | $566,073 | 0.31% |
| Point72 Asset Management, L.P. | 187,622 | $356,482 | 0.2% |
| AQR CAPITAL MANAGEMENT LLC | 15,678 | $29,788 | 0.02% |
% of company = reported institutional shares ÷ shares outstanding. Based on the latest reports; not every holder reports every quarter.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.